Anavex Life Sciences Corp (AVXL)

[Gator328]

Correct. Dr. Missling's job is to advance a drug through the arduous FDA approval process. Catering to the selfish whims of impatient traders doesn't benefit the company in any way other than perhaps reducing the cost of issuing new shares.

I don't even know what more people want him to do to raise the share price. He's kept the float low. He raised money when the stock was in the $20s so there's no shortage of cash. There's minimal debt. He's hired an accomplished scientific advisory board. He got the stock uplisted to Nasdaq and has courted name-brand institutional investors. He's secured patent rights for the next two decades. He admits when things don't work out as expected (i.e., Anavex Plus). He's issued multiple PRs that give every indication things are moving forward nicely. What the market does with that information is out of his control, and so far the market underestimates the odds a small, unknown printing company-turned-biotech will revolutionize CNS research and treatment.

It would be like if your next door neighbor was building a space rocket in his back yard. What odds would you give him for a successful launch? Now imagine that next door neighbor is Elon Musk. Eventually you'd take him more seriously. Dr. Missling can either spend his time trying to convince people the rocket will work or he can spend his time building the rocket and showing people that it works.

I am glad he is choosing to pursue the latter.